Get

Practical

on

Pathways

Value-based care is here. The question now is, how is your organization utilizing pathways to their fullest in order to realize the most benefit? Enter the Clinical Pathways Congress. Year 3 of the Congress gets very practical—it has been designed to dive in and address the operational questions raised by cancer center directors, clinical pathways directors, medical and pharmacy benefit managers, pathway vendors, and other stakeholders involved on pathway committees—about design, development, implementation, utilization, and outcome measurement.

  • How do we best analyze our patient data?

  • How do we incentivize care coordination and pathways adherence?

  • How does our pathways platform compare to others?

  • How do we build, improve, or expand our pathways program?

  • How do we measure outcomes?

The meeting where the pathways conversation turns to action.

This program is focused on the critical questions surrounding clinical pathways and the opportunities to develop new strategies that address evidence-based care through:

Design

AND TESTING

Implementation

AND EVALUATION

Impact

ON QUALITY OF CARE, COSTS, AND HEALTH OUTCOMES

2017 Participating Organizations Included:

  • Cleveland Clinic

  • Harvard Medical School

  • Cancer Treatment Centers of America

  • Lilly

  • Express Scripts

  • Dana Farber Cancer Institute

  • Pfizer Oncology

  • Moffitt Cancer Center

  • Flatiron Health

  • Eisai

  • McKesson Specialty Health

  • Roswell Park Cancer Institute

  • Thomas Jefferson University Hospital

  • Janssen Biotech

  • Knight Cancer Institute

  • Stanford University Medical Center

  • Genentech

  • AmerisourceBergen

  • Maryland Oncology Hematology

  • NYU Langone Medical Center

  • Seattle Cancer Care Alliance

  • Evicore Healthcare

Highlights

Shape

your knowledge of clinical pathways–the program features sessions addressing pathway design, testing, implementation, standards, measurement, and evaluation.

Share

ideas, concerns, challenges, discoveries, and success stories with a community of multidisciplinary stakeholders.

Shed

misconceptions you may have about pathways by connecting with leading faculty with expertise of how to ensure pathways are safe, effective, and evidence-based.

Steering Committee

Alan Balch
PhD

Chief Executive Officer

Patient Advocate Foundation

Hampton, Virginia

Aymen Elfiky
MD, MSc, MBA

Instructor of Medicine

Harvard Medical School

Instructor of Medical Oncology

Dana-Farber Cancer Institute

Boston, Massachusetts

Joan S. McClure
MS

Senior Vice President, Clinical Information and Publications

National Comprehensive Cancer Network (NCCN)

Ft. Washington, Pennsylvania

Sandeep "Bobby" Reddy
MD

Chief Medical Officer

NantHealth

Culver City, California

 

Robin T. Zon
MD, FACP, FASCO

Chair, ASCO Pathways Task Force

Vice President, Finance & Quality Chair

Vice President, Michiana Hematology-Oncology, PC

Mishawaka, Indiana

Keep Me Informed

Contact Us